JB Chemicals' Stock Plummets Over 13% in 6 Months Amid Financial Concerns and Stake Sale
Click to start listening
Synopsis
JB Chemicals and Pharmaceuticals Limited has witnessed a significant drop in its shares, declining over 13% in the last six months due to weak financial results and concerns over stake sales. The company's latest quarter performance has further unsettled investor confidence as market volatility rises.
Key Takeaways
- JB Chemicals shares down 13.15% in 6 months.
- YTD loss of 11.86%.
- Stake sale plans by promoter raised concerns.
- Poor QoQ performance in Q3 FY25.
- Market cap at Rs 1.24 lakh crore.
New Delhi, April 21 (NationPress) The shares of JB Chemicals and Pharmaceuticals Limited have experienced a notable decline in recent times, decreasing by Rs 250.65 or 13.15% in the past six months.
The downward trajectory has persisted into 2025, with the stock losing Rs 222.80 or 11.86% year-to-date (YTD). Annually, the shares have decreased by Rs 132.55 or 7.41%.
Despite the stock closing nearly unchanged on the National Stock Exchange (NSE) on Monday at Rs 1,655.40, a minor increase of Rs 9.10 or 0.55%, the overall market sentiment remains cautious.
The decline in JB Chemicals' shares can be linked to March 27, when the stock dropped 7.4% in a single trading session.
This sharp decrease followed reports indicating that its promoter, Tau Investment Holdings Pte, intended to sell a 10.2% stake in the company through block transactions.
The anticipated offer price was around Rs 1,625 per share, valuing the deal at roughly Rs 2,576 crore.
On that day, the stock fell 6.55% on the Bombay Stock Exchange (BSE) while the broader market was performing well, with the BSE Sensex up by 0.32%.
The company's market capitalization was approximately Rs 1.24 lakh crore, with a 52-week high of Rs 2,029 and a 52-week low of Rs 1,434.85.
Compounding the challenges, JB Chemicals reported a disappointing quarter-on-quarter (QoQ) performance in Q3 FY25.
Revenue fell by 3.71% compared to the preceding quarter, while net profit decreased by 6.92%.
While the company did show year-on-year growth, the sequential decline shook investor confidence.
As of December 2024, Tau Investment Holdings held a 53.66% stake in the firm.
“Concerns regarding stake dilution, weaker-than-anticipated financials, and increasing market volatility have collectively contributed to the ongoing drop in the stock price,” reports indicated.
